Brief

"On February 6, 2025, Anvisa conducted a Public Hearing to discuss the revision of regulatory marks for registering and notifying phytotherapics. The report covers comments, questions, and responses from participants on Public Consultations (CP) 1290/2024, 1291/2024, 1292/2024, and 1293/2024, as well as contributions received in these consultations."

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies